|
|
|
Volumn , Issue 29, 2008, Pages 18-31
|
|
Antiretroviral therapy in adults: January 2008
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR;
AMPRENAVIR PHOSPHATE;
ANTIRETROVIRUS AGENT;
ATAZANAVIR;
CD4 ANTIGEN;
DIDANOSINE;
EFAVIRENZ;
EMTRICITABINE;
ENZYME INHIBITOR;
HEPATITIS B VACCINE;
INDINAVIR;
INTEGRASE INHIBITOR;
LAMIVUDINE;
LAMIVUDINE PLUS ZIDOVUDINE;
LOPINAVIR;
LOPINAVIR PLUS RITONAVIR;
NELFINAVIR;
NEVIRAPINE;
PROTEINASE INHIBITOR;
PYRAZINAMIDE;
RIFABUTIN;
RIFAMPICIN;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
TENOFOVIR DISOPROXIL;
TUBERCULOSTATIC AGENT;
UNINDEXED DRUG;
ZIDOVUDINE;
ANEMIA;
ARTICLE;
ASTHENIA;
BLOOD TOXICITY;
BODY FAT DISTRIBUTION;
BONE DENSITY;
BONE MARROW SUPPRESSION;
BONE MARROW TOXICITY;
CD4 LYMPHOCYTE COUNT;
CENTRAL NERVOUS SYSTEM DISEASE;
CIRCUMORAL PARESTHESIA;
COHORT ANALYSIS;
CRANIOFACIAL MALFORMATION;
DIARRHEA;
DNA SYNTHESIS INHIBITION;
DRUG CLASSIFICATION;
DRUG CLEARANCE;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG ERUPTION;
DRUG HYPERSENSITIVITY;
DRUG INDUCED HEADACHE;
DRUG POTENTIATION;
DRUG SUBSTITUTION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSLIPIDEMIA;
EMBRYOTOXICITY;
EVENING DOSAGE;
FATIGUE;
FATTY LIVER;
FETUS DISEASE;
GASTROINTESTINAL SYMPTOM;
GILBERT DISEASE;
HAIR LOSS;
HEALTH PRACTITIONER;
HEPATITIS;
HEPATITIS B;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERBILIRUBINEMIA;
HYPERCHOLESTEROLEMIA;
HYPERGLYCEMIA;
HYPERLACTATEMIA;
HYPERLIPIDEMIA;
HYPERPIGMENTATION;
HYPERTRIGLYCERIDEMIA;
INFERTILITY;
KIDNEY FAILURE;
LACTIC ACIDOSIS;
LIPOATROPHY;
LIPODYSTROPHY;
LIVER DISEASE;
LIVER DYSFUNCTION;
LIVER TOXICITY;
LOW DRUG DOSE;
MORTALITY;
MYALGIA;
MYOPATHY;
NAUSEA;
NEPHROLITHIASIS;
NEUTROPENIA;
NONHUMAN;
ORAL BLISTER;
PANCREATITIS;
PATIENT COMPLIANCE;
PERIPHERAL NEUROPATHY;
PORTAL HYPERTENSION;
PRACTICE GUIDELINE;
PREGNANCY;
PROTEIN SYNTHESIS INHIBITION;
QUALITY OF LIFE;
RISK REDUCTION;
SIDE EFFECT;
SINGLE DRUG DOSE;
SOUTH AFRICA;
SUPERINFECTION;
TASTE DISORDER;
TERATOGENICITY;
THROMBOCYTOPENIA;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TREATMENT PLANNING;
TUBERCULOSIS;
UNSPECIFIED SIDE EFFECT;
VIRUS LOAD;
|
|
EID: 44649193749
PISSN: 16089693
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|